← All cases

German diagnostic client

Early Cancer Detection Platform

~€10M savings · €50M+ revenue potential

Background

Clinical imaging is a highly competitive market where innovation is largely driven by hardware. Differentiating from other strong products inside the company's own portfolio became the strategic priority for future growth and market positioning.

Solution

A cloud-based, AI-driven early cancer detection platform integrating multiple diagnostic offerings, connecting diagnostic data sources for comprehensive, patient-centric insights. Two objectives in one move: clear differentiation from traditional clinical imaging, and an optimised patient journey with stronger market acceptance.

Results

Migration from on-premise to cloud: globally scalable, with savings of roughly €10M. Global cross-functional R&D teams established (IT, biology, medical, analytics). Multi-omics innovation and SaaS-based clinical products with revenue potential exceeding €50M.

inite's role

inite developed the concept to identify and leverage the portfolio's unique differentiators, led the design and implementation of the digital solution, and delivered a user-friendly interface for both patients and healthcare professionals.

“inite's strength lies in designing and implementing effective systems and structures that significantly improve efficiency and ways of working. The ability to align these changes with stakeholder needs rather than imposing them consistently builds trust.”

Global Head of Oncology R&D · Diagnostic Company